Focal ST-segment elevation without coronary occlusion: myocardial infarction with no obstructive coronary
Casey Meizinger1, Bruce Klugherz2
1Department of Internal Medicine, Abington Hospital, Jefferson Health Abington, 1200 Old York Road PA, 19118, USA.
Insights
This case report highlights a patient with COVID-19 who experienced myocardial infarction with no obstructive coronary atherosclerosis (MINOCA). It emphasizes that not all myocardial injury in COVID-19 is due to blocked arteries, necessitating further research into cardiovascular complications.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) is known for respiratory failure but also presents cardiovascular complications.
- A subset of COVID-19 patients exhibit ST-elevations on ECG with normal coronary angiography, fitting criteria for myocardial infarction with no obstructive coronary atherosclerosis (MINOCA).
- Non-coronary myocardial injury in COVID-19 patients requires further investigation.
Purpose of the Study:
- To present a case of COVID-19 associated with MINOCA.
- To underscore the importance of considering non-obstructive coronary artery disease causes for myocardial injury in COVID-19.
- To encourage further research into the cardiovascular manifestations of COVID-19.
Main Methods:
- Case report of an 86-year-old male with acute hypoxic respiratory failure and ECG findings suggestive of myocardial infarction.
- Initiation of mechanical ventilation and performance of transthoracic echocardiography.
- Coronary angiography revealing no obstructive coronary artery disease; COVID-19 positivity confirmed.
Main Results:
- The patient presented with ST-segment elevation on ECG and confirmed COVID-19.
- Coronary angiography showed no significant coronary artery disease, consistent with MINOCA.
- Despite intensive care, the patient's outcome was unfavorable.
Conclusions:
- The presented case suggests a likely association between COVID-19 and MINOCA.
- It is critical to recognize that myocardial injury in COVID-19 may not stem from obstructive coronary artery disease.
- Consideration of hypoxic respiratory failure, myocarditis, and systemic inflammation is vital in COVID-19 cardiovascular complications.
Background:
While it is understood that coronavirus disease 2019 (COVID-19) is primarily complicated by respiratory failure, more data are emerging on the cardiovascular complications of this disease. A subset of COVID-19 patients present with ST-elevations on electrocardiogram (ECG) yet normal coronary angiography, a presentation that can fit criteria for myocardial infarction with no obstructive coronary atherosclerosis (MINOCA). There is little known about non-coronary myocardial injury observed in patients with COVID-19, and we present a case that should encourage further conversation and study of this clinical challenge.
Case Summary:
An 86-year-old man presented to our institution with acute hypoxic respiratory failure and an ECG showing anteroseptal ST-segment elevation concerning for myocardial infarction. Mechanic ventilation was initiated prior to presentation, and emergent transthoracic echocardiography reported an ejection fraction of 50-55%, with no significant regional wall motion abnormalities. Next, emergent coronary angiography was performed, and no significant coronary artery disease was detected. The patient tested positive for COVID-19. Despite supportive management in the intensive care unit, the patient passed away.
Discussion:
We present a case of COVID-19 that is likely associated with MINOCA. It is crucial to understand that in COVID-19 patients with signs of myocardial infarction, not all myocardial injury is due to obstructive coronary artery disease. In the case of COVID-19 pathophysiology, it is important to consider the cardiovascular effects of hypoxic respiratory failure, potential myocarditis, and significant systemic inflammation. Continued surveillance and research on the cardiovascular complications of COVID-19 is essential to further elucidate management and prognosis.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
